In the present study, we found that the effects of exenatide wereassociated with activation of p-Akt, which may suppress fatty acid oxidation geneand promote hepatocyte regeneration, thus inhibiting the development of NAFLD. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.